A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older (Q38220556)

31 August 2017

A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older (English)

1 reference

31 August 2017

1 reference

A Steens

1

0 references

author name string

D F Vestrheim

2

1 reference

31 August 2017

I S Aaberge

3

1 reference

31 August 2017

B S Wiklund

4

1 reference

31 August 2017

J Storsaeter

5

1 reference

31 August 2017

M A Riise Bergsaker

6

1 reference

31 August 2017

K Rønning

7

1 reference

31 August 2017

E Furuseth

8

1 reference

31 August 2017

16 June 2014

1 reference

Epidemiology and Infection

31 August 2017

1 reference

31 August 2017

142

1 reference

31 August 2017

2471-2482

1 reference

31 August 2017

12

1 reference

Survival and cause of death after traumatic spinal cord injury. A long-term epidemiological survey from Denmark.

31 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Diabetes and infection: is there a link?--A mini-review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Causes of death in patients with celiac disease in a population-based Swedish cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Vaccination in patients with chronic rheumatic or autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Cochlear implants in children: surgical site infections and prevention and treatment of acute otitis media and meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Risk of bacterial meningitis in children with cochlear implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Infectious diseases associated with complement deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Drug interactions and immunosuppression in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Postsplenectomy sepsis and its mortality rate: actual versus perceived risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Primary immunodeficiencies associated with pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Pneumococcal vaccine response in cirrhosis and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Efficacy of pneumococcal vaccination in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Welders are at increased risk for invasive pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

The risk of hospitalisation for infectious pneumonia in mineral dust exposed industries

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

The effect of pneumonia on mortality among patients hospitalized for acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Serotype replacement in disease after pneumococcal vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Coeliac disease and risk of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Lobar pneumonia: an occupational disease in welders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Effectiveness of Immunoglobulin Replacement Therapy on Clinical Outcome in Patients with Primary Antibody Deficiencies: Results from a Multicenter Prospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Response to conjugate pneumococcal and Haemophilus influenzae type b vaccines in asplenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Community-Acquired Recurrent Bacterial Meningitis in Adults

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Identification of new risk factors for pneumonia: population-based case-control study

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Risk of pneumococcal disease in individuals without a spleen

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Immunogenicity of pneumococcal vaccine in renal transplant recipients--three year follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Pneumococcal infection in patients with coeliac disease

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Update on immunizations in solid organ transplant recipients: what clinicians need to know

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

Increased mortality from infectious pneumonia after occupational exposure to inorganic dust, metal fumes and chemicals

1 reference

https://api.crossref.org/works/10.1017%2FS0950268814001514

7 January 2021

10.1017/S0950268814001514

Identifiers

DOI

1 reference

31 August 2017

1 reference